Survival after primary prevention implantable cardioverter-defibrillator placement among patients with chronic kidney disease.

ABSTRACT:

Background

Guidelines recommend that implantable cardioverter-defibrillator (ICD) candidates have an estimated longevity of ≥1 year. Longevity can be affected by chronic kidney disease (CKD).

Methods and results

Using the National Cardiovascular Data Registry ICD registry linked with the Social Security Death Master File, we assessed the rate of death after primary prevention ICD placement between January 1, 2006, and December 31, 2007, according to CKD stage. Using Cox models, we identified factors associated with death among patients with CKD. Compared with patients without CKD (n=26,056), those with CKD (n=21,226) were older, less commonly men, more often white, and more frequently had comorbid illness. Compared with patients without CKD, patients with a glomerular filtra

SUBMITTER: Hess PL 

PROVIDER: S-EPMC4206571 | biostudies-literature | 2014 Oct

REPOSITORIES: biostudies-literature